Skip to main content

Table 1 Patient characteristics

From: Prognostic significance of supradiaphragmatic lymph node metastasis detected by 18F-FDG PET/CT in advanced epithelial ovarian cancer

  total n % PET_CT stage III (n, %) PET_CT stage IV by SdLNM (n, %) PET_CT stage IV by other (n, %) p-value
median Age (years, IQR) 176 100 108 55.9 40 22.4 28 19.7 0.627
55 (48–63) 54 (47–63) 55 (49–63) 55 (48–60)
median initial CA-125 (U/mL, IQR) 848.05 (334.97–2387.32) 659.35 (296.20–2446.90) 1111.80 (712.0–2483.15) 1048.15 (148.45–2111.65) 0.130
FIGO stage
 IIIB 11 6.3 8 7.4 3 7.5 0 0.0  
 IIIC 100 56.8 76 70.4 13 32.5 11 39.3  
 IVA 4 2.3 3 2.8 1 2.5 0 0.0  
 IVB 61 34.7 21 19.4 23 57.5 17 60.7 0.502
Histology
 high grade serous 136 77.3 82 75.9 34 85.0 20 71.4  
 others 40 22.7 26 24.1 6 15.0 8 28.6 0.423
Grade
 1 14 8.0 10 9.3 2 5.0 2 7.1  
 2 59 33.5 38 35.2 13 32.5 8 28.6  
 3 88 50.0 50 46.3 23 57.5 15 53.6 0.122
 unknown 15 8.5   0.0   0.0   0.0  
Residual disease (NGR vs other)
 NGR 38 25.9 23 26.1 10 27.8 5 21.7  
 any residuals 109 74.1 65 72.2 26 72.2 18 78.3 0.804
 unknown 29   20   4   5   
  1. NGR No gross residual disease